Heart stent with new polymer matches Abbott top seller in study - (Yahoo!News via NewsPoints Desk)

  • Study results presented at the American College of Cardiology’s scientific meeting suggest that Terumo’s Nobori drug-coated stent was as effective as Abbott Laboratories' Xience stent at preventing repeat procedures, as reported in Yahoo!News.
  • In the study of more than 3200 patients, Terumo's Nobori met its primary goal of non-inferiority to the Xience stent one year after implantation, with 4.2 percent of patients in both groups requiring a repeat procedure.
  • Patients also had low similar rates of stent thrombosis.

Did you like this article?